TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard


➔ TerrAscend
CSE Ticker: TER
OTCQX Ticker: TRSSF
Market Focus: Global
Classification: Vertical Integration
Country: Canada
Employees: ~1000 as of 08/2021
Established: 2014
CEO: Jason Wild

Summary

Fiscal Year-End: December
Facilities: 5
Dried Flower: Production and Sale
Extracts: Production and Sale
Number of Patients: N/A
Headquarters: Mississauga, ON

Financials (06/30/21)

Cash on hand: $154.2 million
Fixed Investment: $144.9 million
Shareholders’ Equity: $233.5 million
Revenues – Last Quarter: $58.7 million
Adj. Gross Margin : 59.1%
EPS : -$0.14

Capital Structure (08/19/21)

Last Financing: 18.12 million shares at C$12.35
As-Converted Shares: 237.6 million
Warrants: 62.6 million
Options: 13.7 million
Diluted Shares: 314.0 million

Company Brief

TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey and California in addition to operating as a licensed producer in Canada. TerrAscend operates an award-winning chain of Apothecarium dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts. TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market.

The Company owns a number of synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, State Flower, Valhalla Confections and Arise Bioscience Inc.


Highlights

  • Multi-state operator in the U.S.; nationwide distributor of hemp-derived CBD products; Canadian LP with global distribution; and drug development and R&D platform
  • Management comprised of leaders from healthcare, pharmaceutical, banking, cannabis, online grocery industries and CPG
  • Strategic investors include Canopy Growth, Canopy Rivers, and JW Funds
  • $80.5 million loan from strategic partner Canopy Growth
  • Unique ability to sell THC and CBD products within Canada and the U.S.through TerrAscend’s manufacturing footprint
  • Brand portfolio including premium cannabis Haven St., Valhalla Premium Edibles, Funky Farms, Original Hemp, State Flower, Ilera, Kind Tree, Legend and Prism

Growth Strategy

  • Multi-state operator (MSO) in the U.S. focused on key markets: Pennsylvania, New Jersey, Maryland and California
  • Canadian LP concentrating on production and manufacturing of cannabinoid products for medical and adult-use consumers; 40+ SKUs in the market (flower, vapes, tea and edibles)
  • Focus on developing protectable intellectual property assets
  • Creating quality brands that resonate with patients and consumers
  • Plans to leverage The Apothecarium Dispensary brand and store model across the U.S.
  • U.S. nationwide distribution of hemp-derived CBD products through Arise Bioscience; access to 10,000+ stores

Differentiators

  • Proven consolidator with M&A expertise in the highly fragmented U.S. cannabis industry
  • First operator with scaled operations in both the U.S. and Canada
  • One of 12 vertically integrated entities in New Jersey; ability for 240,000 square feet of production and cultivation space and three retail licenses
  • Top wholesale market share in Pennsylvania’s limited license market via Ilera Healthcare; 144,000 square feet of production and cultivation space and six operating dispensaries; distributes to 100% of the state’s medical cannabis dispensaries
  • 20,000 square feet of cultivation and production space, five open dispensaries in California market
  • Multi-year brand licensing agreement with Cookies in New Jersey

Institutional Analyst Coverage

Glenn. G. Mattson
Ladenburg Thalmann

Eric Des Lauriers, CFA
Craig-Hallum Capital Group

Russell Stanley
Beacon Securities Limited

Noel Atkinson
Clarus Securities

Pablo Zuanice
Cantor Fitzgerald

Kenric S. Tyghe
AltaCorp Capital

Matt McGinley
Needham

Andrew Partheniou
Stifel | GMP

Andrew Semple
Echelon

Vivien Azer
Cowen


Curated Stories & News


Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.